Is field trip health a psychedelics stock?

Field Trip Health stock on Thursday finished higher in its first day on the Nasdaq, making it the latest psychedelics-focused company hoping to use a big U.S. exchange to attract investors. Sorry, the video player failed to load. (Error Code: 100013)

Who is field trip's lead investor?

In March, Field Trip completed a bought-deal offering of around 14.7 million shares at around 6.50 Canadian dollars apiece, for a total of 95 million Canadian dollars. The lead investor was Soleus Capital, a health care investment firm. Levy said Field Trip had been in early conversations with some pharma companies.

How do I contact fieldtrip health?

The official website for the company is www.fieldtriphealth.com. The company can be reached via phone at833 222 0084. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.

How did field trip health (ftrp) perform in the quarter?

Field Trip Health Ltd. (NASDAQ:FTRP) issued its earnings results on Monday, November, 15th. The company reported ($0.90) EPS for the quarter, missing analysts' consensus estimates of ($0.75) by $0.15. The company earned $0.72 million during the quarter, compared to analyst estimates of $1.10 million.